Jayson Bedford
Stock Analyst at Raymond James
(3.82)
# 663
Out of 5,143 analysts
324
Total ratings
54.07%
Success rate
7.52%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $32.50 | -16.92% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $494.02 | +22.06% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $19.90 | -4.52% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $114.58 | +27.42% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $246.28 | -15.14% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $99.87 | +13.15% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $152.47 | +18.06% | 22 | Aug 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $108 → $102 | $82.43 | +23.74% | 28 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Strong Buy | $99 → $102 | $73.09 | +39.55% | 31 | Jul 31, 2025 | |
| BSX Boston Scientific | Maintains: Strong Buy | $121 → $124 | $75.15 | +65.00% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $245.25 | +46.79% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $204 → $185 | $175.35 | +5.50% | 7 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $182.49 | +47.95% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $11.43 | -12.51% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $227 → $271 | $112.12 | +141.71% | 12 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $24.41 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $26.90 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $82.40 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $20.63 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $96.75 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $8.23 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $86 | $75.35 | +14.13% | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.42 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $11.53 | - | 3 | Jan 2, 2018 |
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $32.50
Upside: -16.92%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $494.02
Upside: +22.06%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $19.90
Upside: -4.52%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $114.58
Upside: +27.42%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $246.28
Upside: -15.14%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $99.87
Upside: +13.15%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $152.47
Upside: +18.06%
Merit Medical Systems
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $82.43
Upside: +23.74%
DexCom
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $73.09
Upside: +39.55%
Boston Scientific
Jul 24, 2025
Maintains: Strong Buy
Price Target: $121 → $124
Current: $75.15
Upside: +65.00%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $245.25
Upside: +46.79%
May 7, 2025
Maintains: Outperform
Price Target: $204 → $185
Current: $175.35
Upside: +5.50%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $182.49
Upside: +47.95%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $11.43
Upside: -12.51%
Dec 20, 2023
Maintains: Outperform
Price Target: $227 → $271
Current: $112.12
Upside: +141.71%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $24.41
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $26.90
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $82.40
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $20.63
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $96.75
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $8.23
Upside: -
Nov 5, 2020
Maintains: Outperform
Price Target: $75 → $86
Current: $75.35
Upside: +14.13%
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $1.42
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $11.53
Upside: -